medac GmbH for Clinical Special Preparations
PolandAll medications by this manufacturer
-
Bcg — medac
Form: powder and solvent for preparation of suspension for bladder
Active substance Dosage live BCG cells min. 2x10^8 max. 3x10^9 ATC: L03AX03
-
Bendamustine medac
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine 26.1 mg ATC: L01AA09
-
Bleomedac
Form: powder for preparation of injection solution
Active substance Dosage bleomycin sulfate 15000 j.m. ATC: L01DC01
-
Carboplatin
Form: solution for infusion, concentrate
Active substance Dosage carboplatin 10 mg/ml ATC: L01XA02
-
Detimedac 100 mg
Form: powder for preparation of solution for injection or infusion
Active substance Dosage Dacarbazine 100 mg ATC: L01AX04
-
Detimedac 1000 mg
Form: solution for infusion, powder for preparation of
Active substance Dosage Dacarbazine 1000 mg ATC: L01AX04
-
Detimedac 200 mg
Form: powder for preparation of solution for injection or infusion
Active substance Dosage Dacarbazine 200 mg ATC: L01AX04
-
Detimedac 500 mg
Form: solution for infusion, powder for preparation of
Active substance Dosage Dacarbazine 500 mg ATC: L01AX04
-
Epimedac 2 mg/ml solution for injection
Form: solution for injection
Active substance Dosage epirubicin hydrochloride 2 mg/ml ATC: L01DB03
-
Fluorouracil medac
Form: solution for injection
Active substance Dosage 5-fluorouracil 500 mg/10 ml ATC: L01BC02
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage Sodium methotrexate 7.5 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage Sodium methotrexate 12.5 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage Sodium methotrexate 10 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 15 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 17.5 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage Sodium methotrexate 20 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 22.5 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 25 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage Sodium methotrexate 27.5 mg ATC: L01BA01
-
Metex pen
Form: solution for injection in a syringe
Active substance Dosage Sodium methotrexate 30 mg ATC: L01BA01
-
Navirel
Form: solution for infusion, concentrate
Active substance Dosage vinorelbine 10 mg ATC: L01CA04
-
Topotecan medac
Form: solution for infusion, concentrate
Active substance Dosage topotecan 1 mg/ml ATC: L01XX17
-
Urokinase medac
Form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 10000 j.m. ATC: B01AD04
-
Urokinase medac
Form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 50000 j.m. ATC: B01AD04
-
Urokinase medac
Form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 100000 j.m. ATC: B01AD04
-
Urokinase medac
Form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 250000 j.m. ATC: B01AD04
-
Urokinase medac
Form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 500000 mg ATC: B01AD04
-
Vinorelbine medac
Form: capsules, soft gelatin
Active substance Dosage vinorelbine tartrate 27.7 mg ATC: L01CA04
-
Vinorelbine medac
Form: capsules, soft gelatin
Active substance Dosage vinorelbine tartrate 41.55 mg ATC: L01CA04
-
Vinorelbine medac
Form: capsules, soft gelatin
Active substance Dosage vinorelbine tartrate 110.8 mg ATC: L01CA04